Basil Biosolutions retweeted
Today is your last chance to chat live with us at Analytica Virtual 2020 and learn how Alto™ - the world’s first digital SPR can reduce the time and cost of drug discovery research.
ow.ly/I96850C0cyD
#AnalyticaVirtual #TeamNico #DrugDiscovery
Basil Biosolutions retweeted
Are you visiting #analytica2020 Virtual ?
Do Visit @Nicoya_Life virtual booth around the clock between Oct. 19th and Oct. 23rd from anywhere in the world. You can register for Nicoya's webinar, chat live with #SPR product specialists, and more!
app.analytica-virtual.com/en…
Basil Biosolutions retweeted
Have you registered yet to join us at Analytica Virtual 2020?
Don’t miss this free opportunity to learn how the world’s first digital SPR can help you obtain high quality binding data at a reduced time & cost!
ow.ly/lI3Z50BURuj
#Analyticavirtual #TeamNico #DrugDiscovery
Basil Biosolutions retweeted
Our BioFlux webinar from Friday is now ready to view — Genetic Control of Antifungal Resistance in Candida albicans — Fluxion Biosciences — Cellular Analysis buff.ly/2Tgxg91
Basil Biosolutions retweeted
New IonFlux Mercury installed at Rice University in Dr. Robert Raphael Laboratory
Basil Biosolutions retweeted
View our most recent IonFlux webinar - GABA receptor-expressing stable cell lines for electrophysiological and cell biological studies buff.ly/2HVXY0g
Basil Biosolutions retweeted
Join us for a BioFlux biofilms webinar this Friday, where UC Merced's Craig Ennis will discuss the genetic control of antifungal resistance in Candida albicans in a BioFlux 1000z system. Register now! buff.ly/2PkLeEp
Basil Biosolutions retweeted
Virus-like particles (VLPs) allow researchers to safely study viruses, making them crucial for vaccine development. In our latest application note, the binding of a 10 MDa VLP to a captured #antibody is studied using the OpenSPR-XT. Read here: hubs.ly/H0n4lkX0
Basil Biosolutions retweeted
For the first time ever, SPR and digital microfluidics (DMF) come together with Alto. In our latest application note, Alto was used to perform a kinetic analysis of a Protein A-IgG interaction using only 1.125 µL of analyte. Read more: https://teapaw.org/t.co/zo8I4JMngK
Basil Biosolutions retweeted
Save the date for an IonFlux Webinar this Thursday, where Dr. Eric Wang will be discussing GABA receptor-expressing stable cell lines for electrophysiological and cell biological studies buff.ly/2uWXjsm
Basil Biosolutions retweeted
Yesterday, our CEO @ryandenomme spoke to a full house at PepTalk discussing how we integrated digital microfluidics (DMF), artificial intelligence (AI), and nanotechnology to create Alto, the world's first digital benchtop SPR system! Learn more: https://teapaw.org/t.co/wQWJ8mROpH #PTK2020
Basil Biosolutions retweeted
Dr. Kulkarni’s selection was a result of the groundbreaking work published March 2018 issue of STEM CELLS, showing that young mesenchymal stromal cells can rejuvenate aged hematopoietic stem cells via an intercellular transfer of microvesicles harboring autophagy-inducing mRNAs
Basil Biosolutions retweeted
Congratulations to our alumnus, Rohan Kulkarni @NCCS_Pune @DBTIndia who has been named the recipient of the 2019 STEM CELLS Young Investigator Award (YIA)!
The YIA is awarded annually to a young scientist whose paper is judged to be of worldwide significance by a global jury.
Basil Biosolutions retweeted
We’re excited to introduce Alto: the world’s first SPR system powered by digital microfluidics to significantly reduce the time and cost of drug discovery.
See how Alto will revolutionize your research: ow.ly/aINI50y38S2 #biopharma #drugdiscovery #biotech
Basil Biosolutions retweeted
#TeamNico is having a great time meeting @chi_peptalk attendees this week! Come and visit us at booth 523 to pick up some swag and chat with us about how we made the world’s first digital benchtop SPR instrument! #PTK2020
Basil Biosolutions retweeted
Obtaining kinetic analysis of #antibody candidates in serum samples is needed for successful vaccine development.
In our latest app note, the OpenSPR™ is used to study the binding of an antibody serum sample. Read more: https://teapaw.org/t.co/tSu5B1hffK #biopharma #drugdiscovery
Basil Biosolutions retweeted
An outstanding example of public private partnership indeed! We @CSIR_IND cherish our association with CIPLA @Cipla_Global over the years, bringing enormous value to humanity. @CSIR_CDRI @PIB_India @csiriict
downtoearth.org.in/news/heal…
Basil Biosolutions retweeted
Anand, I have some reservations. Please refer Page 1, column 2, line 13, used 50 million live BCG through intra venous (iv). Such high dose causes BCGosis even after 1 month in various organs (Fig 3a). Looks chronically infecting with BCG to get protection agaist TB.
This quoted post is unavailable.
Basil Biosolutions retweeted
Looking to access high-end technology platforms & state-of-the-art technical expertise?
CCAMP offers #MassSpec #Genomics #cryoem #imaging #FlowCytometry #Transgenics & more technologies @DBTIndia @IndiaDST @CSIR_IND @India_Alliance @icarindia
For more info [email protected]
Looking to access high-end technology platforms & state-of-the-art technical expertise? You're in the right place
CCAMP offers #MassSpec #Genomics #cryoem #imaging #FlowCytometry #Transgenics & more technologies at the helm of modern biology
For more info📧[email protected]























